New combo therapy takes on advanced cancers
NCT ID NCT07639450
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a new drug called N-3C01, given alone or with an immunotherapy, in people with advanced solid tumors that have spread or cannot be removed. The main goals are to check safety, find the right dose, and see if the combination shrinks tumors. About 114 adults aged 18-75 with good performance status may join.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Corner Edith & Platt Streets, , NSW 2298 Australia
Waratah, New South Wales, 2298, Australia
Contact
Contact
-
GenesisCare Research
Saint Leonards, New South Wales, 2065, Australia
Contact
Contact
-
Henan Cancer Hospital
Zhengzhou, Zhengzhou, 450000, China
Contact
Contact
-
Hunan Cancer Hospital
Changsha, Hunan, 410013, China
Contact
Contact
-
San Clinical Trials Unit
Wahroonga, New South Wales, 2076, Australia
Contact
Contact
-
Shanghai East Hospital
Shanghai, Shanghai Municipality, 200000, China
Contact
Contact